Therapeutic Human Polyclonals' Acquisition

Therapeutic Human Polyclonals was acquired by Roche Holding on April 02, 2007.

Therapeutic Human Polyclonals (THP) is an emerging biotechnology company focused on research in the field of human antibody technologies. THP has developed a unique transgenic mammalian platform to cr…

Articles about Therapeutic Human Polyclonals' Acquisition: